Sequencing

Life Technologies Continues Position As Leader in Sequencing Market

For more than two decades the Applied Biosystems™ division of Life Technologies has been the leading provider of instruments across the sequencing spectrum. From gold-standard technologies for DNA sequencing by capillary electrophoresis to the award winning SOLiD™ System for next generation sequencing, we've continually brought innovation to our customers through cutting edge technologies. Now we continue this rich history with the development of a single molecule sequencing platform that offers the accuracy and flexibility to support molecular medicine.


First Generation Second Generation Third Generation

Genetic Analyzers

SOLiD™ 4 & 4hq

SOLiD™ PI System

Single Molecule Sequencing

Gold Standard in CE sequencing

Enables path to translate discoveries from NGS platforms to diagnostics

3500 Series CE IVD registered and targeting 510(k) clearance in 2011

Scalable system ensures continual access to innovation

Unprecedented throughput and accuracy provide highest quality, lowest cost genome

Unsurpassed versatility supports multiple applications

Affordable price makes sequencing accessible to every lab

Powerful system with 50Gb mappable sequence with 99.99% accuracy

Can be optimized for speed, throughput, or number of samples

Streamlined workflows and intuitive software

Easy-to-use sample prep without difficult or biasing circularization

Highest accuracy and read lengths using Qdot® (FRET) chemistry

Flexible, scalable platform unrestricted by hardware or imaging technology

Preview of technology at AGBT 2010

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)